NBK Capital Holds US$217 Million First Close (MENA)

NBK Capital, an alternative investment firm focused on growth capital in middle market companies throughout the MENA region, has reached a first close on its second private equity fund, NBK Capital Equity Partners Fund II, with US$217 million in capital commitments. The fund will continue the firm’s strategy of… Read More

Mekong Capital Exits Three Vietnamese Technology Companies (Asia)

Vietnam-focused private equity firm Mekong Capital has exited its investments in three Vietnam-based technology companies: Ngo Han, MK Smart and Digiworld. Last month, Mekong Capital sold its entire 29.7 percent stake worth VND101.2 billion (approximately US$4.8 million) in magnet wire producer Ngo Han to the company’s Chairwoman Ngo Thi… Read More

Darby Exits India-based Symbiotec Pharmalab, Actis Ups Stake (Asia)

Darby Overseas Investments, the private equity arm of Franklin Templeton Investments, has exited its investment in India-based active pharmaceutical ingredients manufacturer Symbiotec Pharmalab to pan-emerging markets private equity firm Actis. Last month, Actis invested US$48 million for a significant minority stake in the company and has subsequently increased its… Read More

Blackstone Buys Stake in Chinese Mall Developer (Asia)

Global investment and advisory firm The Blackstone Group and investment banking service provider ICBC International have purchased a 40 percent and a six percent stake, respectively, in China-based mall developer and operator SCP Company. Blackstone’s investment, which was structured through Blackstone Real Estate Partners Asia, is reported to be… Read More

Goldman Sachs Exits IL&FS Transportation Networks (Asia)

The private equity arm of Goldman Sachs has exited its investment in India-listed IL&FS Transportation Networks, a subsidiary of IL&FS that develops and manages toll roads. Goldman Sachs, through GS Strategic Investments, sold a 1.3 percent stake, or around 2.6 million shares, on 31 October on the National Stock… Read More

CNEI Completes US$25.4 Million Investment in Chinese Biopharmaceutical Company (Asia)

China New Enterprise Investment (CNEI), a China-focused growth capital fund manager, has invested US$25.4 million in China-based biopharmaceutical company Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (FDZJ). CNEI completed the transaction in two steps, investing US$21 million earlier this year and an additional US$4.4 million in October. The firm acquired a 17 percent… Read More

The Abraaj Group Sells Stake in Opalia Pharma (MENA)

Global growth markets investor The Abraaj Group has announced its full exit from Tunisia-based pharmaceutical company Opalia Pharma. The Abraaj Group, which originally invested in Opalia in 2009, sold its entire stake to Italy-listed Recordati, an international pharmaceutical company. In addition to The Abraaj Group’s stake, Recordati has agreed… Read More

Affinity Seals a US$123 Million Dairy Joint Venture with Chinese SOE (Asia)

Asia-focused buyout fund manager Affinity Equity Partners has invested US$123 million in a dairy farming joint venture with Chinese state-owned enterprise (SOE) Beijing Capital Agribusiness Group, also known as Sunlon. Sunlon will spin-out its dairy farming operation into the joint venture, taking a 60 percent stake to Affinity’s 40… Read More

Bamboo Finance Exits Mongolia-based XacBank (Asia)

Global microfinance private equity investor Bamboo Finance has exited from its investment in TenGer Financial Group, the holding company of Mongolia-based banking institution XacBank, in a sale to a group of investors led by Japan-based leasing company ORIX Corporation. XacBank operates in all of Mongolia’s 21 provinces and the… Read More



(default archive template)